Provisional patent application submitted
Know-how based
Licensee
Development partner
Commercial partner
Investment
University spin out
A hydrogel is a network of polymer chains that have a tendency to mix with or dissolve in water. Interest in hydrogels has been increasing because they are not harmful to living tissue and have an ability to mimic soft biological tissue. Biodegradable hydrogels are of particular interest for many medical applications because they can be used to control the release of encapsulated molecules over an extended period of time. This can also eliminate the need to implant and remove medical devices from the body. As such, there is a growing demand for hydrogels with tunable degradability.
Researchers at Saint Louis University have developed hydrolytically degradable polyethylene glycol (PEG) crosslinkers to control the degradation of PEG hydrogels. Degradation rates can span from hours to months.
The potential benefits of this technology include:
Minimize the harshness of preparation conditions
Minimize acidic degradation of products
Increase suitability for cell encapsulation
Minimize protein activity loss upon encapsulation
Minimize patient inflammation caused by drug delivery mechanisms
Increase degradability of drug delivery mechanisms
Increase degradation times from hours to months
Increase tunability of degradation for drug delivery mechanisms
Potential applications of this technology include:
Delivery of localized proteins.
Delivery of biologics.
Delivery of medications to treat mental illness.
Saint Louis University is seeking partners to further develop and commercialize this technology.